{"id":"https://openalex.org/W2019921670","doi":"https://doi.org/10.1016/s1567-5769(03)00132-2","title":"Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice","display_name":"Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice","publication_year":2003,"publication_date":"2003-06-30","ids":{"openalex":"https://openalex.org/W2019921670","doi":"https://doi.org/10.1016/s1567-5769(03)00132-2","mag":"2019921670","pmid":"https://pubmed.ncbi.nlm.nih.gov/12890429"},"language":"en","primary_location":{"id":"doi:10.1016/s1567-5769(03)00132-2","doi":"https://doi.org/10.1016/s1567-5769(03)00132-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5769(03)00132-2","pdf_url":null,"source":{"id":"https://openalex.org/S158377717","display_name":"International Immunopharmacology","issn_l":"1567-5769","issn":["1567-5769","1878-1705"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Immunopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103493450","display_name":"Yoshifumi Taniguchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshifumi Taniguchi","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc, Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc, Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078804188","display_name":"Keizo Kohno","orcid":"https://orcid.org/0000-0001-9864-7491","observed_orcids":["https://orcid.org/0000-0001-9864-7491"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]},{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Keizo Kohno","raw_affiliation_strings":["Department of Bioresource Science and Technology, Hiroshima University Graduate School of Biosphere Science, Kagamiyama 1-4-4, Higashihiroshima 739-8528, Japan","Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Bioresource Science and Technology, Hiroshima University Graduate School of Biosphere Science, Kagamiyama 1-4-4, Higashihiroshima 739-8528, Japan","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shin-ichiro Inoue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin-ichiro Inoue","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050132111","display_name":"Satomi Koya\u2010Miyata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satomi Koya-Miyata","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019488016","display_name":"Iwao Okamoto","orcid":"https://orcid.org/0000-0001-6051-0879","observed_orcids":["https://orcid.org/0000-0001-6051-0879"]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Iwao Okamoto","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057283487","display_name":"Norie Arai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norie Arai","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006850931","display_name":"Kanso Iwaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kanso Iwaki","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masao Ikeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masao Ikeda","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103372479","display_name":"Masashi Kurimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Kurimoto","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Fujisaki 675-1, Okayama 702-8006, Japan","institution_ids":["https://openalex.org/I4210104993"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078804188"],"corresponding_institution_ids":["https://openalex.org/I113306721","https://openalex.org/I4210104993"],"apc_list":{"value":3220,"currency":"USD","value_usd":3220},"apc_paid":null,"fwci":5.2779,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.95445231,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"3","issue":"9","first_page":"1313","last_page":"1324"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.8389000296592712,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.8389000296592712,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11386","display_name":"Bee Products Chemical Analysis","score":0.10419999808073044,"subfield":{"id":"https://openalex.org/subfields/1109","display_name":"Insect Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/royal-jelly","display_name":"royal jelly","score":1.0},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8849999904632568},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.9879999756813049},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.8410000205039978},{"id":"https://openalex.org/keywords/th1-th2-balance","display_name":"Th1/Th2 balance","score":0.8119999766349792},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7319999933242798},{"id":"https://openalex.org/keywords/nc-nga-mice","display_name":"NC/Nga mice","score":0.7789999842643738},{"id":"https://openalex.org/keywords/skin-inflammation","display_name":"skin inflammation","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.8919749855995178},{"id":"https://openalex.org/C2778027074","wikidata":"https://www.wikidata.org/wiki/Q202501","display_name":"Royal jelly","level":2,"score":0.786450982093811},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6649317741394043},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4824598431587219},{"id":"https://openalex.org/C2780765947","wikidata":"https://www.wikidata.org/wiki/Q12033531","display_name":"Administration (probate law)","level":2,"score":0.46436047554016113},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.37945452332496643},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3657705783843994},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3218807876110077},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1526241898536682},{"id":"https://openalex.org/C31903555","wikidata":"https://www.wikidata.org/wiki/Q1637030","display_name":"Food science","level":1,"score":0.06618130207061768},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000099219","descriptor_name":"Royal Jelly","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003877","descriptor_name":"Dermatitis, Contact","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003877","descriptor_name":"Dermatitis, Contact","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003877","descriptor_name":"Dermatitis, Contact","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003877","descriptor_name":"Dermatitis, Contact","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006241","descriptor_name":"Haptens","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D006984","descriptor_name":"Hypertrophy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007073","descriptor_name":"Immunoglobulin E","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007073","descriptor_name":"Immunoglobulin E","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008817","descriptor_name":"Mice, Mutant Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010853","descriptor_name":"Picryl Chloride","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013047","descriptor_name":"Specific Pathogen-Free Organisms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019001","descriptor_name":"Nitric Oxide Synthase","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052247","descriptor_name":"Nitric Oxide Synthase Type II","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s1567-5769(03)00132-2","doi":"https://doi.org/10.1016/s1567-5769(03)00132-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5769(03)00132-2","pdf_url":null,"source":{"id":"https://openalex.org/S158377717","display_name":"International Immunopharmacology","issn_l":"1567-5769","issn":["1567-5769","1878-1705"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Immunopharmacology","raw_type":"journal-article"},{"id":"pmid:12890429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12890429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International immunopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W391181190","https://openalex.org/W1543202257","https://openalex.org/W1546445911","https://openalex.org/W1606476961","https://openalex.org/W1646743268","https://openalex.org/W1970140945","https://openalex.org/W1991195369","https://openalex.org/W1991484350","https://openalex.org/W1997033326","https://openalex.org/W2001416665","https://openalex.org/W2003080015","https://openalex.org/W2003293386","https://openalex.org/W2007650463","https://openalex.org/W2014592293","https://openalex.org/W2015776844","https://openalex.org/W2015941743","https://openalex.org/W2022587490","https://openalex.org/W2029491963","https://openalex.org/W2038682607","https://openalex.org/W2045024700","https://openalex.org/W2047976786","https://openalex.org/W2062093468","https://openalex.org/W2062384555","https://openalex.org/W2071374363","https://openalex.org/W2079282933","https://openalex.org/W2086594222","https://openalex.org/W2101237312","https://openalex.org/W2103229419","https://openalex.org/W2113127336","https://openalex.org/W2137722996","https://openalex.org/W2145110135","https://openalex.org/W2146872665","https://openalex.org/W2154376533","https://openalex.org/W2159837806","https://openalex.org/W2270159809","https://openalex.org/W2312870247","https://openalex.org/W2573443582"],"related_works":["https://openalex.org/W2266526338","https://openalex.org/W2086594222","https://openalex.org/W2035559775","https://openalex.org/W2019526679","https://openalex.org/W1970072392","https://openalex.org/W1895530076","https://openalex.org/W2323015467","https://openalex.org/W2956091184","https://openalex.org/W7166804226","https://openalex.org/W2108792256"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}